Abstract
Voice agents built as cascaded automatic speech recognition (ASR)->large language model (LLM)-> text-to-speech (TTS) pipelines increasingly rely on conversational TTS: streaming, context conditioned models that adapt delivery to dialogue history. Such models are natural and expressive but offer little explicit control over how rare, trust-critical drug names are pronounced, because these entities are too infrequent, and their vocabulary too fast-growing, to be covered by any amount of pre-, mid-, or post-training. We retrofit phoneme controllability onto a pretrained conversational TTS model without any pre/mid-training, using an ARPAbet vocabulary exten-sion, continued phoneme-augmented supervised fine-tuning (SFT), and a training-free inference-time acoustic-biasing step. On a 7,500 clip clinical drug-pronunciation evaluation, our model raises strict Gemini-judged correctness from 54.6% (no phoneme augmentation) to 90.7%, outperforming every conversational and stateless TTS baseline on the automatic metric. Because no training stage sees a drug name, the entire evaluation is out-of-domain, so the gains reflect learned pronunciation rather than memorization. In a blinded, randomized human study, adult listeners judge 84% of our clips correct, versus 82% for the strongest baseline, with overlapping confidence intervals on a stratified subset. Across all 250 matched clips, Gemini agrees with the human majority on 84.8% of binary labels (k{appa}=0.57).
Abstract: arXiv descriptive metadata (CC0). Thank you to arXiv for use of its open access interoperability. This service was not reviewed or approved by, nor does it necessarily express or reflect the policies or opinions of, arXiv.
Record
- Archive ID
- arxiv:2610.24164
- Published
- Oct 16, 2026
- arXiv
- 2610.24164
- Categories
- cs.CL, eess.AS
- Provenance
- arxiv